TD Cowen started coverage on shares of Geron (NASDAQ:GERN – Free Report) in a research report sent to investors on Monday morning, MarketBeat reports. The firm issued a buy rating and a $10.00 price objective on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Wedbush reaffirmed an outperform […]

Related Keywords

China , , Needham Company , Geron Corporation , Pathstone Family Office , Goldman Sachs Group , Hermes Inc , Peaks Wealth Advisors , China Universal Asset Management Co , Sg Americas Securities , Free Report , Moderate Buy , Get Free Report , Family Office , Universal Asset Management , Twin Peaks Wealth Advisors , Geron Daily , Rgeron , Nasdaq Gern , Egern , Medical , 37416310 , Initiated Coverage , Td Cowen ,